Pathogen-driven decision for implant retention in the management of infected total knee prostheses.
about
Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.Evaluation of a Genus- and Group-Specific Rapid PCR Assay Panel on Synovial Fluid for Diagnosis of Prosthetic Knee InfectionAggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements.The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement - a literature reviewDo diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens?One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus.The Role of Highly Selective Implant Retention in the Infected Hip Arthroplasty.Partial component-retained two-stage reconstruction for chronic infection after uncemented total hip arthroplasty: results of sixteen cases after five years of follow-up.Staphylococcus aureus versus streptococci in orthopaedic infections.Inhibitory effects of vancomycin and fosfomycin on methicillin-resistant Staphylococcus aureus from antibiotic-impregnated articulating cement spacers.Infection and revision rates following primary total knee arthroplasty in patients with rheumatoid arthritis versus osteoarthritis: a meta-analysis.Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study
P2860
Q28071834-5435816F-15FD-41B0-AC52-2ACFD80F91DDQ36163096-1D74900D-D265-4329-8DBC-31CCCE95E237Q36434428-525CC108-40B3-480E-A033-8B33CCC8085AQ37570739-29E802EB-7AFE-4EF5-B7F2-607DEB986A71Q37579464-9C7EC52F-8088-4272-8CA9-32D8459BB3A4Q38257503-9DA321E4-339B-4FEE-B39C-E6EDB64B231DQ38924258-9324DFB2-E318-495D-8713-10D7D01D29F0Q39135819-7B082793-8EBA-424C-B045-1495905BE15EQ39662351-76EE3B0D-0281-4C5C-AC74-010A67955399Q40196827-BCDE519D-6DFB-4422-B55A-0EBEFF5235DEQ40228462-D2D48EE8-CAF8-4BC4-B36C-DD41E2E079CDQ40309331-83A29294-A5BF-4121-BC1B-49082594951BQ40548394-2F65D971-488E-45E5-AC5D-8B788E8AE3F9Q41126065-710F166D-5CE0-4DD8-98F0-A47B23986702Q50893725-CC895CD9-8469-4F2B-BE45-2DC208257868Q58214243-024E18DF-16C1-40D8-B4FC-7EE9382E0AEF
P2860
Pathogen-driven decision for implant retention in the management of infected total knee prostheses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogen-driven decision for i ...... nfected total knee prostheses.
@en
Pathogen-driven decision for i ...... nfected total knee prostheses.
@nl
type
label
Pathogen-driven decision for i ...... nfected total knee prostheses.
@en
Pathogen-driven decision for i ...... nfected total knee prostheses.
@nl
prefLabel
Pathogen-driven decision for i ...... nfected total knee prostheses.
@en
Pathogen-driven decision for i ...... nfected total knee prostheses.
@nl
P2093
P2860
P1476
Pathogen-driven decision for i ...... nfected total knee prostheses.
@en
P2093
Axel Gamulin
Laurence Legout
Line Zürcher-Pfund
Robin Peter
P2860
P2888
P304
P356
10.1007/S00264-013-1923-4
P577
2013-05-22T00:00:00Z